Brazilian Journal of Pain
https://brjp.org.br/article/doi/10.5935/2595-0118.20180028
Brazilian Journal of Pain
Artigo Original

Topical anesthetic to release trigger points in painful myofascial syndrome. Pilot study

Anestésico tópico para liberação de pontos-gatilhos em síndrome dolorosa miofascial. Estudo piloto

Ana Paula de Oliveira Maciel; Matheus Henrique Lopes Dominguete; José Dias da Silva Neto

http://dx.doi.org/10.5935/2595-0118.20180028 BrJP, vol.1, n2, p.147-150, 2018
PDF English
PDF Português
SciELO
Downloads: 0
Views: 537

Abstract

BACKGROUND AND OBJECTIVES: The myofascial syndrome is a painful regional disorder that is characterized by the presence of painful points that cause referred pain in other sites different from the one of origin, known as trigger points. The use of topical anesthetic associated with acupressure to release trigger points helps to alleviate pain during the myofascial release. The objective of this study was to calibrate instruments to evaluate the topical anesthetic action of lidocaine in active myofascial trigger points during the myofascial release procedure.

METHODS: Pilot, prospective study, tied with the Professional Master’s Degree in Health Applied Sciences of the University of Vale do Sapucaí, Pouso Alegre, MG, conducted with the purpose to evaluate the analgesic effect of lidocaine in concentrations of 2, 4 and 7% after 3, 5 and 10 minutes of the application in patients with painful myofascial syndrome.

RESULTS: The descriptive statistics analysis showed a painful response in all lidocaine concentrations related to the evaluated times, except for 7% of lidocaine 10 minutes after the application.

CONCLUSION: The myofascial release was more efficient using lidocaine at 7%, with a ten-minute interval for the anesthetic effect to start the physiotherapy intervention.

Keywords

Anesthetics, Local anesthesia, Lidocaine, Myofascial pain syndromes, Trigger points

Resumo

JUSTIFICATIVA E OBJETIVOS: A síndrome miofascial é uma desordem dolorosa regional que se caracteriza pela presença de pontos dolorosos, que provocam dor referida em outros locais diferentes do de origem, conhecidos como pontos-gatilho. A utilização de anestésico tópico associado a digito-pressão na liberação de pontos-gatilho, tem a finalidade de aliviar a dor durante o procedimento de liberação miofascial. O objetivo deste estudo foi calibrar instrumentos para a avaliação da ação anestésica tópica de lidocaína em pontos-gatilhos miofasciais ativos, durante o procedimento de liberação miofascial.

MÉTODOS: Estudo piloto prospectivo, vinculado ao Mestrado Profissional em Ciências Aplicadas à Saúde da Universidade do Vale do Sapucaí, Pouso Alegre, MG, realizado com a finalidade de avaliar o efeito analgésico do uso de lidocaína em concentrações de 2, 4 e 7% após 3, 5 e 10 minutos da aplicação em pacientes com síndrome dolorosa miofascial.

RESULTADOS: A análise estatística descritiva demonstrou que houve resposta dolorosa em todas as concentrações da lidocaína relacionadas aos tempos avaliados, exceto para 7% de lidocaína após 10 minutos da aplicação.

CONCLUSÃO: A liberação miofascial foi mais eficiente utilizando a lidocaína a 7%, com intervalo de efeito do anestésico para realização da intervenção fisioterápica de 10 minutos.

Palavras-chave

Anestesia local, Anestésicos, Lidocaína, Pontos-gatilho, Síndromes da dor miofascial

Referências

Yeng LT, Hideko H, Kaziyama S, Teixeira MJ. Myofascial pain syndrome. Rev Med. 2001;80(1):94-110.

Borg-Stein J, Iaccarino MA. Myofascial pain syndrome treatments. Phys Med Rehabil Clin N Am. 2014;25(2):357-74.

Dommerholt J, Grieve R, Hooks T, Finnegan M. A critical overview of the current myofascial pain literature - January 2017. J Bodyw Mov Ther. 2017;21(1):141-7.

Fricton J. Myofascial Pain: Mechanisms to management. Oral Maxillofac Surg Clin North Am. 2016;28(3):289-311.

Kuan TS. Current studies on myofascial pain syndrome. Curr Pain Headache Rep. 2009;13(5):365-9.

Simons DG. New views of myofascial trigger points: etiology and diagnosis. Arch Phys Med Rehabil. 2008;89(1):157-9.

Ay S, Konak HE, Evcik D, Kibar S. The effectiveness of Kinesio Taping on pain and disability in cervical myofascial pain syndrome. Rev Bras Reumatol. 2017;57(2):93-9.

Travell JG, Simons DG. Myofascial Pain and Dysfunction: The Trigger Point Manual. 1992.

Shah JP, Thaker N, Heimur J, Aredo J V, Sikdar S, Gerber L. Myofascial trigger points then and now: a historical and scientific perspective. PM&R. 2015;7(7):746-61.

Borg-Stein J, Simons DG. Myofascial pain. Arch Phys Med Rehabil. 2002;83(3^sSuppl 1):S40-7.

Lavelle ED, Lavelle W, Smith HS. Myofascial trigger points. Anesthesiol Clin. 2007;25(4):841-51.

Fisher A. Muscle pain: basic algorithm for pain management. 1995;1(1).

Flores MP, Castro AP, Nascimento J. Analgésicos tópicos. Rev Bras Anestesiol. 2012;62(2):248-52.

Kaweski S. Topical anesthetic creams. Plast Reconstr Surg. 2008;121(6):2161-5.

Gerwin R. Botulinum toxin treatment of myofascial pain: A critical review of the literature. Curr Pain Headache Rep. 2012;16(5):413-22.

Karaca I, Yapca OE, Adiyeke M, Toz E, Karaca S Yildirim. Effect of cervical lidocaine gel for pain relief in pipelle endometrial sampling. Eurasian J Med. 2017;48(3):189-91.

Bron C, Dommerholt J, Stegenga B, Wensing M, Oostendorp RA. High prevalence of shoulder girdle muscles with myofascial trigger points in patients with shoulder pain. BMC Musculoskelet Disord. 2011;12(1):139.

Roman-Torres CV, Brandt WC, Muller KC, Cortelli SC, Aquino DR, Schwartz-Filho HO. Avaliação dos diferentes métodos utilizados no tratamento da síndrome dolorosa miofascial. Rev Gestão Saúde. 2015;12:1-9.

Batalha LM, Carreira MC, Correia MM. Dor para não ter dor: aplicação de anestésico tópico. Rev Enferm Ref. 2011;III Série(5):203-9.

Babaie S, Ghanbarzadeh S, Daravan S, Kouhsoltani M, Samishehkar H. Nanoethosomes for dermal delivery of lidocaine. Adv Pharm Bull. 2015;5(4):549-56.

Kalichman L, David C Ben. Effect of self-myofascial release on myofascial pain, muscle flexibility, and strength: a narrative review. J Bodyw Mov Ther. 2016;21(2):446-51.

Giordano D, Raso MG, Pernice C, Agnoletti V, Barbieri V. Topical local anesthesia: focus on lidocaine-tetracaine combination. Local Reg Anesth. 2015;8:95-100.

Gupta P, Singh V, Sethi S, Kumar A. A comparative study of trigger point therapy with local anaesthetic (0.5% bupivacaine) versus combined trigger point injection therapy and levosulpiride in the management of myofascial pain syndrome in the orofacial region. J Maxillofac Oral Surg. 2016;15(3):376-83.

Weilbach C, Hoppe C, Karst M, Winterhalter M, Raymondos K, Schultz A. Effectiveness of various formulations of local anesthetics and additives for topical anesthesia - a prospective, randomized, double-blind, placebo-controlled study. J Pain Res. 2017;10:1105-9.

Xie P, Qin B, Yang F, Yu T, Yu J, Wang J. Lidocaine injection in the intramuscular innervation zone can effectively treat chronic neck pain caused by MTrPs in the trapezius muscle. Pain Physician. 2015;18(5):E815-26.

Ustun N, Arslan F, Mansuroglu A, Inanoglu D, Yagiz AE, Guler H. Efficacy of EMLA cream phonophoresis comparison with ultrasound therapy on myofascial pain syndrome of the trapezius: A single-blind, randomized clinical study. Rheumatol Int. 2014;34(4):453-7.

Rauck R, Busch M, Marriott T. Effectiveness of a heated lidocaine/tetracaine topical patch for pain associated with myofascial trigger points: results of an open-label pilot study. Pain Pract. 2013;13(7):533-8.

Firmani M, Miralles R, Casassus R. Effect of lidocaine patches on upper trapezius EMG activity and pain intensity in patients with myofascial trigger points: a randomized clinical study. Acta Odontol Scand. 2014;73(3):210-8.

Sobanko JF, Miller CJ, Alster TS. Topical anesthetics for dermatologic procedures: a review. Dermatologic Surg. 2012;38(5):709-21.

Sawynok J. Topical analgesics for neuropathic pain in the elderly: current and future prospects. Drugs Aging. 2014;31(12):853-62.

Bastazini Júnior I, Martins AL, Alves FS, Nascimento DC. Estudo comparativo entre escores de dor após uso de duas preparações de lidocaína tópica. Surg Cosmet Dermatol. 2011;3(1):28-30.

Ellah NH Abd, Abouelmagd SA, Abbas AM, Shaaban OM, Hassanein KM. Dual-responsive lidocaine in situ gel reduces pain of intrauterine device insertion. Int J Pharm. 2018;538(1-2):279-86.

Gooran S, Pourfakhr P, Bahrami S, Yasseri AM Fakhr, Javid A. A randomized control trial comparing combined glandular lidocaine injection and intraurethral lidocaine gel with intraurethral lidocaine gel alone in cystoscopy and urethral dilatation. Urol J. 2017;14(4):4044-7.

Peyronnet B, Drouin SJ, Gomez FD, Seisen T, Goujon A, Pradere B. [Local analgesia during flexible cystoscopy in male patients: a non-inferiority study comparing XylocaineR gel to InstillagelR Lido]. Prog Urol.. 2016;26(11-12):651-5.

Pereira F, Shiroma HF, Urias MG, Yamada VH, Lima AAS, Hofling-Lima AL. Pilot study comparing topical anesthetic agents in pterygium surgery: subconjunctival injection versus 2% lidocaine gel versus 5% lidocaine gel. Cornea. 2018;37(2):194-8.

Okayasu I, Komiyama O, Ayuse T, Laat A De. Effect of topical lidocaine in the oral and facial regions on tactile sensory and pain thresholds. Arch Oral Biol. 2016;72:51-5.

Arab V, Bagheri-Nesami M, Mousavinasab SN, Espahbodi F, Pouresmail Z. Comparison of the effects of hegu point ice massage and 2% lidocaine gel on arteriovenous fistula puncture-related pain in hemodialysis patients: a randomized controlled trial. J Caring Sci. 2017;6(2):141-51.

Submetido em:
29/03/2017

Aceito em:
23/03/2018

5f16322e0e8825a1689517e3 brjp Articles
2595-3192 (Eletrônico) 2595-0118 (Impresso)
BrJP ©2024 Todos os direitos reservados.

BrJP

Share this page
Page Sections